Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients : a referral center study.

Safarnezhad Tameshkel, Fahimeh, Karbalaie Niya, Mohammad Hadi, Zamani, Farhad, Motamed, Nima, Ajdarkosh, Hossein, Vafaeimanesh, Jamshid, Khoonsari, Mahmoodreza, Sohrabi, Masood Reza, Aten, Sima, Azarkeivan, Azita, Eslami, Masoumeh Sadat, Perumal, Dhayaneethie, Maadi, Mansooreh, Ghanbari, Behrooz and Keyvani, Hossein (2020) Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients : a referral center study. Archives of Virology, 165, pp. 2193-2203. ISSN (print) 0304-8608

Actions (Repository Editors)

Item Control Page Item Control Page